HeartBeam, Inc. (BEAT)
Market Cap | 61.04M |
Revenue (ttm) | n/a |
Net Income (ttm) | -19.45M |
Shares Out | 33.73M |
EPS (ttm) | -0.73 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 11,001 |
Open | 1.850 |
Previous Close | 1.879 |
Day's Range | 1.810 - 1.870 |
52-Week Range | 1.450 - 3.480 |
Beta | -0.58 |
Analysts | Buy |
Price Target | 8.00 (+341.99%) |
Earnings Date | May 13, 2025 |
About BEAT
HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting. The company develops three-dimensional vector images of cardiac electrical activity. It is developing HeartBeam AIMIGo, a credit card-sized cloud-based diagnostic software systems to address heart attack detection. The company was incorporated in 2015 and is based in Santa Clara, California. [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to one analyst, the rating for BEAT stock is "Buy" and the 12-month stock price forecast is $8.0.
News

HeartBeam Announces Two New U.S. Patents, Powering Forward Its Robust Patent Portfolio
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces Two New U.S. Patents, Powering Forward Its Robust Patent Portfolio.

HeartBeam Appoints CEO Robert Eno to Board of Directors to Support U.S. Commercialization and Growth
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Appoints CEO Robert Eno to Board of Directors to Support U.S. Commercialization and Growth.

HeartBeam to Host First Quarter 2025 Results Conference Call on Tuesday, May 13, 2025 at 4:30 p.m. Eastern Time
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Host First Quarter 2025 Results Conference Call on Tuesday, May 13, 2025 at 4:30 p.m. Eastern Time.

HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology.

HeartBeam and AccurKardia Announce Strategic Collaboration to Advance Cardiac Monitoring Innovation
SANTA CLARA, Calif. & NEW YORK--(BUSINESS WIRE)--HeartBeam and AccurKardia Announce Strategic Collaboration to Advance Cardiac Monitoring Innovation.

HeartBeam, Inc. (BEAT) Q4 2024 Earnings Call Transcript
HeartBeam, Inc. (NASDAQ:BEAT) Q4 2024 Results Conference Call March 13, 2025 4:30 PM ET Company Participants Rob Eno - Chief Executive Officer Tim Cruickshank - Chief Financial Officer Operator Greet...

HeartBeam Reports Fourth Quarter and Full Year 2024 Results
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Reports Fourth Quarter and Full Year 2024 Results.

HeartBeam to Participate at Upcoming Conferences in Dana Point, California, March 16-21, 2025
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Participate at Upcoming Conferences in Dana Point, California, March 17-21, 2025.

HeartBeam to Host Fourth Quarter Full Year 2024 Results Conference Call on Thursday, March 13, 2025 at 4:30 p.m. Eastern Time
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Host Fourth Quarter Full Year 2024 Results Conference Call on Thursday, March 13, 2025 at 4:30 p.m. Eastern Time.

HeartBeam Announces Exercise and Closing of Underwriter's Over-Allotment Option for Public Offering of Common Stock
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces Exercise and Closing of Underwriter's Over-Allotment Option for Public Offering of Common Stock.

HeartBeam Announces Pricing of $10.0 Million Underwritten Public Offering of Common Stock
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces Pricing of $10.0 Million Underwritten Public Offering of Common Stock.

HeartBeam Achieves Major Milestone with FDA Submission for its Groundbreaking 12-Lead ECG Synthesis Software
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Achieves Major Milestone with FDA Submission for its Groundbreaking 12-Lead ECG Synthesis Software.

HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference.

HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology.

HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference.

HeartBeam, Inc. (BEAT) Q3 2024 Earnings Call Transcript
HeartBeam, Inc. (NASDAQ:BEAT) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET Company Participants Rob Eno - Chief Executive Officer Branislav Vajdic - President and Founder Tim Cruicksh...

HeartBeam Reports Third Quarter 2024 Results
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Reports Third Quarter 2024 Results.

HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time.

HeartBeam Named “Rising Star” at the 6th Annual Digital Health Hub Foundation Awards
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Named “Rising Star” at the 6th Annual Digital Health Hub Foundation Awards.

HeartBeam Appoints Robert Eno as Chief Executive Officer in Preparation for US Commercialization
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Appoints Robert Eno as Chief Executive Officer in Preparation for US Commercialization.

HeartBeam Appoints Dr. Lance Myers as Chief AI Scientist
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Appoints Dr. Lance Myers as Chief AI Scientist.

HeartBeam Names Timothy Cruickshank as Chief Financial Officer
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Names Timothy Cruickshank as Chief Financial Officer.

HeartBeam, Inc. (BEAT) Q2 2024 Earnings Call Transcript
HeartBeam, Inc. (NASDAQ:BEAT) Q2 2024 Earnings Conference Call August 14, 2024 4:30 PM ET Company Participants Branislav Vajdic - Founder and CEO Rob Eno - President Ravi Malhotra - Senior Director, ...

HeartBeam Reports Second Quarter 2024 Results
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Reports Second Quarter 2024 Results.

HeartBeam to Host Second Quarter 2024 Results Conference Call on Wednesday, August 14, 2024 at 4:30 p.m. Eastern Time
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Host Second Quarter 2024 Results Conference Call on Wednesday, August 14, 2024 at 4:30 p.m. Eastern Time.